(VIANEWS) – HØLAND OG SETSKOG (HSPG.OL), RUBIS (RUI.PA), MEDISTIM (MEDI.OL) are the highest payout ratio stocks on this list.
We have collected information regarding stocks with the highest payout ratio up until now. The payout ratio in itself isn’t a promise of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. HØLAND OG SETSKOG (HSPG.OL)
81.4% Payout Ratio
Høland og Setskog Sparebank provides banking services for the retail and corporate markets in Norway. It offers deposits and loans, as well as insurance products. The company was formerly known as Holand Sparebank and changed its name to Høland og Setskog Sparebank in 2010. The company was founded in 1849 and is headquartered in Bjørkelangen, Norway.
Earnings Per Share
As for profitability, HØLAND OG SETSKOG has a trailing twelve months EPS of kr8.6.
PE Ratio
HØLAND OG SETSKOG has a trailing twelve months price to earnings ratio of 15.12. Meaning, the purchaser of the share is investing kr15.12 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.2%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Mar 10, 2023, the estimated forward annual dividend rate is 7 and the estimated forward annual dividend yield is 5.38%.
More news about HØLAND OG SETSKOG.
2. RUBIS (RUI.PA)
75% Payout Ratio
Rubis engages in the operation of bulk liquid storage facilities for commercial and industrial customers in Europe, Africa, and the Caribbean. The company operates through Retail & Marketing, Support & Services, and Renewable Electricity production segments. It operates terminals that provide bulk liquid storage facilities for fuels, chemicals, and agri-food products; and distributes fuels, liquefied gases, bitumen, and lubricants. The company also provides infrastructure, transportation, supply, and services for supporting the development of downstream distribution and marketing activities; and produces photovoltaic electricity. Rubis was incorporated in 1954 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, RUBIS has a trailing twelve months EPS of €2.55.
PE Ratio
RUBIS has a trailing twelve months price to earnings ratio of 8.71. Meaning, the purchaser of the share is investing €8.71 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.87%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jun 13, 2023, the estimated forward annual dividend rate is 1.92 and the estimated forward annual dividend yield is 9.04%.
Yearly Top and Bottom Value
RUBIS’s stock is valued at €22.22 at 17:10 EST, way under its 52-week high of €27.14 and higher than its 52-week low of €20.74.
Volume
Today’s last reported volume for RUBIS is 39076 which is 77.23% below its average volume of 171668.
More news about RUBIS.
3. MEDISTIM (MEDI.OL)
71.09% Payout Ratio
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, MEDISTIM has a trailing twelve months EPS of kr6.33.
PE Ratio
MEDISTIM has a trailing twelve months price to earnings ratio of 32.86. Meaning, the purchaser of the share is investing kr32.86 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.9%.
Moving Average
MEDISTIM’s value is way below its 50-day moving average of kr235.20 and way below its 200-day moving average of kr247.94.
Sales Growth
MEDISTIM’s sales growth is 17.6% for the ongoing quarter and 5.8% for the next.
More news about MEDISTIM.
4. REMY COINTREAU (RCO.PA)
32.46% Payout Ratio
Rémy Cointreau SA, together with its subsidiaries, engages in the production, sale, and distribution of liqueurs and spirits. The company operates through Rémy Martin, Liqueurs & Spirits, and Partner Brands segments. It offers liqueurs, brandy, gin, single malt whisky, rum, wine, and champagne primarily under the Cointreau, Metaxa, St-Rémy, Mount Gay, Bruichladdich, Port Charlotte, Octomore, The Botanist, Westland, LOUIS XIII, and Domaine des Hautes Glaces brands. The company operates in Europe, the Middle East, Africa, the Americas, Asia, Australia, and New Zealand. Rémy Cointreau SA was founded in 1724 and is headquartered in Cognac, France.
Earnings Per Share
As for profitability, REMY COINTREAU has a trailing twelve months EPS of €5.7.
PE Ratio
REMY COINTREAU has a trailing twelve months price to earnings ratio of 26.53. Meaning, the purchaser of the share is investing €26.53 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.18%.
Yearly Top and Bottom Value
REMY COINTREAU’s stock is valued at €151.20 at 17:10 EST, way below its 52-week high of €180.50 and way higher than its 52-week low of €111.45.
Revenue Growth
Year-on-year quarterly revenue growth grew by 2.1%, now sitting on 1.55B for the twelve trailing months.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Sep 28, 2023, the estimated forward annual dividend rate is 2 and the estimated forward annual dividend yield is 1.73%.
Volume
Today’s last reported volume for REMY COINTREAU is 5490 which is 91.96% below its average volume of 68306.
More news about REMY COINTREAU.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, 1’s stock is considered to be overbought (>=80).
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 1%.
Volume
Today’s last reported volume for 1 is 1 which is 1% above its average volume of 1.
More news about 1.
